Concordance for taking ivermectin was slightly higher (86.0 and 84.9 percent, respectively) than for albendazole (81.8 and 83.3 percent) or praziquantel (81.6 and 83.3%) in the 1- and 12-month surveys, but these differences did not reach statistical significance.
← all excerpts
Accuracy of Coverage Survey Recall following an Integrated Mass Drug Administration for Lymphatic Filariasis, Schistosomiasis, and Soil-Transmitted Helminthiasis.
1
—
—